A gentle Triple Acid facial peel specifically formulated with AHA, BHA and PHA to help reduce the appearance of pores, smooth skin texture, and boost radiance.
Our targeted gentle facial peel is specifically formulated with 5.5% AHAs (Glycolic Acid and Lactic Acid), 0.18% BHA (Salicylic Acid), and 3.0% PHA (Gluconolactone) to help reduce the appearance of pores, boost skin’s radiance, and create visibly softer and smoother skin texture. Balanced with soothing Copper Gluconate to help reduce discomfort, our formula provides a gentle exfoliating peel that can be used daily.
What It’s Good For
Helps to visibly reduce the appearance of pores and excess surface oil
Visibly smooths skin texture and creates more even skin tone
Boosts skin’s radiance
Gentle enough for daily use (twice a day)
For all skin types
Sized to meet TSA guidelines
Key Ingredients
SALICYLIC ACID
Salicylic Acid is a beta-hydroxy acid that helps to clarify pores and refine skin texture.
GLYCOLIC ACID
Glycolic Acid is a naturally occurring fruit acid derived from sugar cane known to help smooth skin.
LACTIC ACID
Lactic Acid is an alpha hydroxy acid known for its exfoliation properties. Within our formulas, Lactic Acid helps gently exfoliate skin and diminish the look of fine lines and uneven skin texture.
How to Use
Dispense into palms or saturate a cotton pad
Apply thin layer to clean skin
Do not rinse (safe to use up to twice a day)
Can be applied in the morning and evening
BEFORE AND AFTER
Before and After
At the Kiehl’s labs, we tested the skin to see how deeply within its outer surface layer our targeted facial pre-serum penetrated to improve texture. More blue lines indicate a rougher skin texture that’s less radiant and more uneven. After using Clearly Corrective™ Daily Re-Texturizing Triple Acid Peel, less blue lines show diminished rough texture for smoother, more radiant skin.
Our formula is demonstrated to visibly smooth skin texture:
88% Saw Minimized Pores
91% Agreed Skin Appears Smoother
88% Saw More Radiant Skin
Based on a consumer perception study after 4 weeks of use